Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
LOADING
|||
Switch Symbol:
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 550.53% |
| Q2 2025 | 123.32% |
| Q1 2025 | -275.80% |
| Q4 2024 | -406.62% |
| Q3 2024 | 116.46% |
| Q2 2024 | -739.22% |
| Q1 2024 | 188.98% |
| Q4 2023 | -209.10% |
| Q3 2023 | 255.22% |
| Q2 2023 | -113.96% |
| Q1 2023 | 16.66% |
| Q4 2022 | -1.34% |
| Q3 2022 | 42.47% |
| Q2 2022 | 306.09% |
| Q1 2022 | -83.25% |
| Q4 2021 | -18.92% |
| Q3 2021 | -65.66% |
| Q2 2021 | 870.07% |
| Q1 2021 | -57.94% |
| Q4 2020 | 199.17% |
| Q3 2020 | -47.23% |
| Q2 2020 | 87.43% |
| Q1 2020 | 137.21% |
| Q4 2019 | -97.34% |
| Q3 2019 | -24.89% |
| Q2 2019 | -100.50% |
| Q1 2019 | 2393.42% |
| Q4 2018 | 41.89% |
| Q3 2018 | -66.71% |
| Q2 2018 | 89.45% |
| Q1 2018 | 30.66% |
| Q4 2017 | 71.89% |
| Q3 2017 | 26.72% |
| Q2 2017 | 27.40% |
| Q1 2017 | -47.22% |
| Q4 2016 | 254.10% |
| Q3 2016 | 24.91% |
| Q2 2016 | -71.01% |
| Q1 2016 | 37.04% |
| Q4 2015 | 28.14% |